Dentalcare logo

Adverse Drug Reactions - Part II

COURSE NUMBER: 537

Credit Hours:

3 Hour(s)

The global objectives of the course are to provide a clinical frame of reference for adverse drug reactions (ADRs) and to raise the level of awareness of oral healthcare providers of the spectrum of potential ADRs affecting oral and various...

View More

(Use this feature to create assignments for your students and staff.)

Overview

The global objectives of the course are to provide a clinical frame of reference for adverse drug reactions (ADRs) and to raise the level of awareness of oral healthcare providers of the spectrum of potential ADRs affecting oral and various other tissues and organ systems.


This course discusses common immune-mediated and idiosyncratic adverse drug reactions (ADRs) related to the top 200 drugs dispensed by U.S. community pharmacies and less commonly noted ADRs affecting oral tissues. In addition, uncommon, time-related (delayed), usually dose-related ADRs, i.e., carcinogenesis and teratogenesis, and some secondary ADRs are presented.

  • Intended Audience:

    Dental Assistants, Dental Hygiene Students, Dental Hygienists, Dental Students, Dentists, Dental Assistant Students

  • Date Course Online:

    Jul 31, 2017

  • Last Revision Date:

    Dec 31, 2000

  • Course Expiration Date:

    Jul 30, 2020

  • Cost:

    Free

  • Method:

    Self-instructional

  • AGD Subject Code(s):

Learning Objectives

Upon completion of this course, the dental professional should be able to:


  • Discuss in general terms the mechanisms of immune-mediated, idiosyncratic, oncogenic, teratogenic and secondary ADRs.
  • Discuss the spectrum of potential immune-mediated, idiosyncratic, oncogenic, teratogenic and secondary ADRs.
  • Discuss issues related to preventing, diagnosing, and reporting ADRs.

Disclaimers

Participants must always be aware of the hazards of using limited knowledge in integrating new techniques or procedures into their practice. Only sound evidence-based dentistry should be used in patient therapy. Note:  Registration is required to take test.

Author(s)

Conflict of Interest Disclosure Statement

  • The authors report no conflicts of interest associated with this course.

Submission Information

Recognition

AGD Pace Logo

Approved PACE Program Provider

THE PROCTER & GAMBLE COMPANY


Nationally Approved PACE Program Provider for FAGD/MAGD credit.

Approval does not imply acceptance by any regulatory authority or AGD endorsement.


8/1/2021 to 7/31/2027

Provider ID# 211886